Latham & Watkins LLP represented Terns Pharmaceuticals in the offering and Davis Polk advised the underwriters involved. Terns Pharmaceuticals, Inc. (Nasdaq: TERN), a clinical-stage biopharmaceutical company...
Terns Pharmaceuticals’ $86 Million Common Stock Offering
Trimble’s Acquisition of Transporeon
Skadden advised Trimble on the deal, while Latham & Watkins and Wardynski & Partners advised Hg. POELLATH advised the management of Transporeon. Davis Polk advised BofA...
Prometheus Biosciences’ $500 Million Shares Offering
Wilson Sonsini and Latham & Watkins advised Prometheus Biosciences on the deal, while Davis Polk & Wardwell advised the representatives of the several underwriters. Prometheus Biosciences,...
Biodesix’s $40 Million Shares Offering
Sidley Austin advised Biodesix, while Davis Polk & Wardwell advised the underwriter William Blair in the offering. Biodesix, Inc. executed the offering of 35,075,000 shares (including the...
RAPT Therapeutics’ $75 Million Common Stock Offering
Cooley advised RAPT Therapeutics, while Davis Polk advised the joint book-running managers in the offering. RAPT Therapeutics, Inc. executed a $75 million SEC-registered follow-on offering of 4,054,055...
Brookdale Senior Living’s $125 Million Tangible Equity Units Offering
Davis Polk advised the representatives of the underwriters in the offering. Brookdale Senior Living Inc. executed a $125 million SEC-registered offering of 2,500,000 tangible equity units. BofA...
Zoetis’s $1.35 Billion Senior Notes Offering
Cooley represented Zoetis, while Davis Polk advised the joint book-running managers in the offering. Zoetis Inc. executed its offering of $600 million aggregate principal amount of its...
Tenaya Therapeutics’ $75 Million Shares Offering
Wilson Sonsini Goodrich & Rosati advised Tenaya on the deal, while Davis Polk advised the joint book-running managers and representatives of the several underwriters. Clinical stage...
Metalmark Capital’s $50 Million Investment in Morgenesis
Davis Polk advised Metalmark Capital on the deal. Metalmark Capital executed its investment of up to $50 million in Orgenesis’s U.S.-based point of care services subsidiary, Morgenesis...
Qualcomm’s $1.9 Billion Notes Offering
Cravath represented QUALCOMM Incorporated, while Davis Polk advised the representatives of the several underwriters in the offering. Qualcomm Incorporated executed its SEC-registered offering of $700 million aggregate...
Molded Devices’ Acquisition of GlobalMed and Schauenburg-Truplast
Davis Polk advised Molded Devices on the deal, while Schauenburg Hose Technology Group, GlobalMed Inc. (Canada) and Schauenburg-Truplast (China) were represented by Fasken Martineau DuMoulin LLP....
NextGen Healthcare’s $230 Million Convertible Senior Notes Offering
Latham & Watkins represented NextGen Healthcare, while Davis Polk advised J.P. Morgan Securities LLC, the representative of the initial purchasers in the offering. NextGen Healthcare, Inc....